LENZ Therapeutics (LENZ) Free Cash Flow (2022 - 2023)
Historic Free Cash Flow for Therapeutics (LENZ) over the last 2 years, with Q4 2023 value amounting to -$21.0 million.
- Therapeutics' Free Cash Flow rose 1057.57% to -$21.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$60.4 million, marking a year-over-year increase of 3612.41%. This contributed to the annual value of -$59.9 million for FY2024, which is 91.21% up from last year.
- Latest data reveals that Therapeutics reported Free Cash Flow of -$21.0 million as of Q4 2023, which was up 1057.57% from -$13.1 million recorded in Q3 2023.
- Therapeutics' 5-year Free Cash Flow high stood at -$12.8 million for Q1 2023, and its period low was -$24.5 million during Q1 2022.